智通财经网·2025-12-11 01:46Group 1 - The core viewpoint of the article highlights the significant increase in the stock price of Zhaoyan New Drug (06127), which rose by 7.1% to HKD 18.56, with a trading volume of HKD 42.5682 million [1] - The price of experimental monkeys has surged, with the cost for 3-5 year old macaques reaching HKD 140,000 each, indicating a supply-demand imbalance in the market [1] - Zhaoyan New Drug is identified as the largest supplier of experimental monkeys globally, positioning the company favorably in a market experiencing increased demand due to a resurgence in new drug development [1] Group 2 - According to estimates from Founder Securities, the supply of experimental monkeys is projected to be around 49,000 to 52,400 annually from 2025 to 2027, while the demand is expected to be between 51,300 and 62,600 annually [1] - The short-term outlook suggests that the demand for experimental monkeys will increase due to the recovery in new drug research and development, while improvements on the supply side are expected to be challenging [1] - The ongoing supply-demand gap in the experimental monkey market is likely to widen in the near term, driven by the factors mentioned above [1]